-
Covid Live Updates: J&J Vaccine Ships Out; America's Teachers Reach a Breaking Point
The U.S. is recording at least 67,300 new Covid-19 cases and at least 2,010 virus-related deaths each day, based on a seven-day average of JHU data.
-
Dr. Scott Gottlieb Sees Promising Signs That Covid Vaccines Reduce Virus Transmission
Pfizer board member Dr. Scott Gottlieb told CNBC there is growing evidence showing Covid vaccines cut down on person-to-person spread of the virus.
-
Florida Gov. DeSantis Accused of Favoritism in Distributing Covid Vaccine, Congress Urged to Investigate
Florida democrat Nikki Fried accused DeSantis of “inept distribution of vaccines at best, and corrupt political patronage at worst.”
-
Watch Live: Biden Covid Team Holds Briefing After FDA Clears J&J's One-Shot Vaccine
President Joe Biden’s Covid-19 response team is holding a news briefing on the coronavirus pandemic
-
J&J CEO Says Single-Shot Covid Vaccine Will Keep People Out of the Hospital, Prevent Deaths
CEO Alex Gorsky told CNBC that J&J’s newly approved vaccine will be an important tool in the fight against the pandemic.
-
Covid Updates: New Group Could Be Eligible for Stimulus Payments; J&J Details Severe Vaccine Reactions
The U.S. is recording at least 73,300 new Covid-19 cases and at least 2,160 virus-related deaths each day, based on a seven-day average of JHU data.
-
CDC Director Signs Off on J&J's Single-Shot Covid Vaccine, Clearing Way for Distribution to Begin
CDC Director Dr. Rochelle Walensky said Friday that she would “stand by to review” the ACIP’s recommendation and be “ready to sign.”
-
FDA Approves Johnson & Johnson's Single-Shot Covid Vaccine for Emergency Use
The FDA has approved J&J’s Covid-19 vaccine for emergency use, giving the U.S. a third tool to fight the pandemic.
-
Johnson & Johnson Board Member Says 20 Million Covid Vaccine Doses Will Be Delivered by the End of March
Johnson & Johnson board member Dr. Mark McClellan says the company expects 20 million Covid vaccine doses delivered by the end of March.
-
FDA Panel Unanimously Recommends Third Covid Vaccine as J&J Wins Key Vote in Path to Emergency Use
The full FDA is likely to approve the Johnson & Johnson Covid vaccine as early as Saturday with distribution to the states next week.
-
J&J Says Two Trial Participants Had Severe Allergic Reactions After Getting Covid Vaccine
Two people suffered severe allergic reactions shortly after getting Johnson & Johnson’s Covid-19 vaccine, a J&J scientist told an FDA panel.
-
CDC Director Warns Recent Decline in U.S. Covid Cases May Have Stalled as Variants Spread
The CDC director warned Friday the recent decline in U.S. Covid cases may have stalled as variants spread.
-
CDC Scientist Says US Is âNowhere Close' to Herd Immunity
The presence of more transmissible coronavirus variants requires a higher proportion of the population to be immune to achieve the benchmark.
-
Biden Administration Taps Private Companies, Business Groups for Help in Covid Fight
The White House urged businesses across the country to require masking and social distancing on premises and to help employees get vaccinated against Covid-19.
-
Watch Live: Biden Covid Team Holds Press Briefing as U.S. Daily Cases Begin to Level Off
President Joe Biden’s Covid-19 response team will hold a press briefing Friday where officials plan to announce a new partnership with top business groups.
-
Israeli Data Suggest Mass Vaccinations Led to Drop in Severe Covid Cases, CDC Study Finds
“Taken together, these results suggest reduced rates of severe COVID-19 following vaccination,” the researchers wrote.
-
CDC Study Finds Nursing Home Residents Who Appear to Have Recovered From Covid Were Reinfected With an Even Worse Case
A new CDC study released on Thursday suggests some people may be susceptible to coronavirus reinfection and could have worse outcomes later on.
-
5 Things to Know Before Key FDA Panel Votes on J&J's Single-Shot Covid Vaccine Today
A key FDA panel is to vote on whether to recommend J&J’s Covid vaccine for emergency use, which would help pave the way for a third vaccine in the U.S.
-
Covid Updates: Pfizer Explores Ways to Fight New Variants; 20 Million Americans Are Fully Vaccinated
The U.S. is recording at least 72,200 new Covid-19 cases and at least 2,150 virus-related deaths each day, based on a seven-day average of JHU data.
-
Moderna Moves Forward on Plan to Increase Covid Vaccine Supply in Each Vial After Latest FDA Feedback
Moderna said it received “positive feedback” from the FDA on its proposal to increase the number of Covid-19 vaccine doses in each of its vials.